• A large Korean self-controlled case series study explicitly states that, compared with the influenza vaccine, the mRNA COVID-19 vaccine did not show a significant difference in the incidence of myelitis¹.
• The U.S. National Academies of Sciences, Engineering, and Medicine reviewed epidemiologic studies and found no evidence suggesting a large association between COVID-19 vaccines and transverse myelitis; the evidence is inadequate to accept or reject even a small association²³.
• Systematic reviews have identified very few post-COVID-19 vaccination myelitis cases globally (31 patients across 28 studies)⁴, while influenza vaccines have long been recognized in the literature as a reported cause of vaccine-associated myelitis⁵.
• No credible study or pharmacovigilance analysis supports a 31-fold increase in myelitis risk from COVID-19 vaccines versus flu shots; the claim is directly contradicted by comparative safety data.

Overall validity: 0%

1. The association between acute transverse myelitis and COVID‐19 ...
2. Chapter: 3 Neurologic Conditions and COVID-19 Vaccines
3. Neurologic Conditions and COVID-19 Vaccines - NCBI - NIH
4. Clinical characteristics, radiological features and prognostic factors of transverse myelitis following COVID-19 vaccination: A systematic review
5. Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature - PMC